Jason N Johnson1, Christoph P Hornik1, Jennifer S Li1, Daniel K Benjamin1, Terry T Yoshizumi1, Robert E Reiman1, Donald P Frush1, Kevin D Hill2. 1. From the Division of Pediatric Cardiology (J.N.J., C.P.H., J.S.L., K.D.H.) and Division of Radiology (T. T. Y., R.E.R., D.P.F.), Department of Pediatrics, Duke University Medical Center, Durham, NC; and Duke Clinical Research Institute, Durham, NC (J.S.L., D.K.B., K.D.H.). 2. From the Division of Pediatric Cardiology (J.N.J., C.P.H., J.S.L., K.D.H.) and Division of Radiology (T. T. Y., R.E.R., D.P.F.), Department of Pediatrics, Duke University Medical Center, Durham, NC; and Duke Clinical Research Institute, Durham, NC (J.S.L., D.K.B., K.D.H.). kevin.hill@duke.edu.
Abstract
BACKGROUND: Children with heart disease are frequently exposed to imaging examinations that use ionizing radiation. Although radiation exposure is potentially carcinogenic, there are limited data on cumulative exposure and the associated cancer risk. We evaluated the cumulative effective dose of radiation from all radiation examinations to estimate the lifetime attributable risk of cancer in children with heart disease. METHODS AND RESULTS: Children ≤6 years of age who had previously undergone 1 of 7 primary surgical procedures for heart disease at a single institution between 2005 and 2010 were eligible for the study. Exposure to radiation-producing examinations was tabulated, and cumulative effective dose was calculated in millisieverts. These data were used to estimate lifetime attributable risk of cancer above baseline using the approach of the Committee on Biological Effects of Ionizing Radiation VII. The cohort included 337 children exposed to 13 932 radiation examinations. Conventional radiographs represented 92% of examinations, whereas cardiac catheterization and computed tomography accounted for 81% of cumulative exposure. Overall median cumulative effective dose was 2.7 mSv (range, 0.1-76.9 mSv), and the associated lifetime attributable risk of cancer was 0.07% (range, 0.001%-6.5%). Median lifetime attributable risk of cancer ranged widely depending on surgical complexity (0.006%-1.6% for the 7 surgical cohorts) and was twice as high in females per unit exposure (0.04% versus 0.02% per 1-mSv effective dose for females versus males, respectively; P<0.001). CONCLUSIONS: Overall radiation exposures in children with heart disease are relatively low; however, select cohorts receive significant exposure. Cancer risk estimation highlights the need to limit radiation dose, particularly for high-exposure modalities.
BACKGROUND:Children with heart disease are frequently exposed to imaging examinations that use ionizing radiation. Although radiation exposure is potentially carcinogenic, there are limited data on cumulative exposure and the associated cancer risk. We evaluated the cumulative effective dose of radiation from all radiation examinations to estimate the lifetime attributable risk of cancer in children with heart disease. METHODS AND RESULTS:Children ≤6 years of age who had previously undergone 1 of 7 primary surgical procedures for heart disease at a single institution between 2005 and 2010 were eligible for the study. Exposure to radiation-producing examinations was tabulated, and cumulative effective dose was calculated in millisieverts. These data were used to estimate lifetime attributable risk of cancer above baseline using the approach of the Committee on Biological Effects of Ionizing Radiation VII. The cohort included 337 children exposed to 13 932 radiation examinations. Conventional radiographs represented 92% of examinations, whereas cardiac catheterization and computed tomography accounted for 81% of cumulative exposure. Overall median cumulative effective dose was 2.7 mSv (range, 0.1-76.9 mSv), and the associated lifetime attributable risk of cancer was 0.07% (range, 0.001%-6.5%). Median lifetime attributable risk of cancer ranged widely depending on surgical complexity (0.006%-1.6% for the 7 surgical cohorts) and was twice as high in females per unit exposure (0.04% versus 0.02% per 1-mSv effective dose for females versus males, respectively; P<0.001). CONCLUSIONS: Overall radiation exposures in children with heart disease are relatively low; however, select cohorts receive significant exposure. Cancer risk estimation highlights the need to limit radiation dose, particularly for high-exposure modalities.
Authors: Adam L Dorfman; Reza Fazel; Andrew J Einstein; Kimberly E Applegate; Harlan M Krumholz; Yongfei Wang; Emmanuel Christodoulou; Jersey Chen; Ramon Sanchez; Brahmajee K Nallamothu Journal: Arch Pediatr Adolesc Med Date: 2011-01-03
Authors: Daniel J Podberesky; Erin Angel; Terry T Yoshizumi; Greta Toncheva; Shelia R Salisbury; Christopher Alsip; Alessandra Barelli; John C Egelhoff; Colin Anderson-Evans; Giao B Nguyen; David Dow; Donald P Frush Journal: AJR Am J Roentgenol Date: 2012-11 Impact factor: 3.959
Authors: John D Mathews; Anna V Forsythe; Zoe Brady; Martin W Butler; Stacy K Goergen; Graham B Byrnes; Graham G Giles; Anthony B Wallace; Philip R Anderson; Tenniel A Guiver; Paul McGale; Timothy M Cain; James G Dowty; Adrian C Bickerstaffe; Sarah C Darby Journal: BMJ Date: 2013-05-21
Authors: Brian P Quinn; Aimee K Armstrong; Holly D Bauser-Heaton; Ryan Callahan; Howaida G El-Said; Susan R Foerster; Bryan H Goldstein; Andrea S Goodman; Todd M Gudausky; Jacqueline N Kreutzer; Ryan A Leahy; Christopher J Petit; Toby A Rockefeller; Shabana Shahanavaz; Sara M Trucco; Lisa Bergersen Journal: Pediatr Cardiol Date: 2018-11-30 Impact factor: 1.655
Authors: Jason N Johnson; Christoph P Hornik; Jennifer S Li; Daniel K Benjamin; Terry Yoshizumi; Robert E Reiman; Donald P Frush; Kevin D Hill Journal: Circulation Date: 2015-04-21 Impact factor: 29.690
Authors: John W Kakareka; Anthony Z Faranesh; Randall H Pursley; Adrienne Campbell-Washburn; Daniel A Herzka; Toby Rogers; Josh Kanter; Kanishka Ratnayaka; Robert J Lederman; Thomas J Pohida Journal: IEEE J Transl Eng Health Med Date: 2018-03-01 Impact factor: 3.316